Insider Transactions in Q3 2022 at Ginkgo Bioworks Holdings, Inc. (DNA)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2022
|
Reshma Kewalramani Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,818
+10.84%
|
-
|
|
Sep 30
2022
|
Jason R Kelly Director |
BUY
Exercise of conversion of derivative security
|
Direct |
773,453
+50.0%
|
-
|
|
Sep 30
2022
|
Reshma P. Shetty Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
773,453
+50.0%
|
-
|
|
Sep 30
2022
|
Reshma P. Shetty Director |
BUY
Exercise of conversion of derivative security
|
Direct |
773,453
+50.0%
|
-
|
|
Sep 30
2022
|
Marie E. Fallon Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,134
+50.0%
|
-
|
|
Sep 30
2022
|
Mark E. Dmytruk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,361
+50.0%
|
-
|
|
Sep 30
2022
|
Barry Canton > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Indirect |
773,453
+50.0%
|
-
|
|
Sep 30
2022
|
Barry Canton > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Direct |
773,453
+50.0%
|
-
|
|
Aug 02
2022
|
Kathy Hopinkah Hannan Director |
BUY
Grant, award, or other acquisition
|
Direct |
56,986
+47.9%
|
-
|